The safety and efficacy of midlines compared to peripherally inserted central catheters for adult cystic fibrosis patients: A retrospective, observational study

International Journal of Nursing Studies

Volumn 51, Issue 5, 2014, Pages 694-702

  Sharp, Rebecca ^a   Esterman, Adrian ^a   McCutcheon, Helen ^b   Hearse, Neville ^c   Cummings, Melita ^c  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Catheterisation adverse effects; Catheters vascular; Cystic fibrosis; Midlines; Observational; Peripherally inserted central catheters

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ADVERSE EFFECTS; AUSTRALIA; CENTRAL VENOUS CATHETERIZATION; CYSTIC FIBROSIS; DEVICES; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CATHETERIZATION, CENTRAL VENOUS; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SOUTH AUSTRALIA; YOUNG ADULT;

EID: 84897044089     PISSN: 00207489     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijnurstu.2013.09.002     Document Type: Article

References (52)

1. Anderson N. Midline catheters: the middle ground of intravenous therapy administration. Journal of Infusion Nursing 2004, 27(5):313-321.
2. Balfour-Lynn I., Malbon K., Burman J., Davidson S. Thrombophilia in children with cystic fibrosis. Pediatric Pulmonology 2005, 39(4):306-310.
3. Bilton D. Cystic fibrosis. Medicine 2008, 36(5):273-278.
4. Bui S., Babre F., Hauchecorne S., Christoflour N., Ceccato F., Boisserie-Lacroix V., Clouzeau H., Fayon M. Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis. Journal of Cystic Fibrosis 2009, 8(5):326-331.
5. Burton D. Spirometry tests. Australian Pharmacist 2010, 29(8):682-685.
6. Centers for Disease Control and Prevention Guidelines for the Prevention of Intravascular Catheter-Related Infections 2011, http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf.
7. Chen W., Liu T., Wu S., Tan T., Tseng H., Shih C. Improving diagnosis of central venous catheter-related bloodstream infection by using differential time to positivity as a hospital-wide approach at a cancer hospital. Journal of Infection 2009, 59(5):317-323.
8. Cummings M., Hearse N., McCutcheon H., Deuter K. Improving antibitoic treatment outcomes through the implementation of a midline: piloting a change in practice for cystic fibrosis patients. Journal of Vascular Nursing 2011, 24(1):11-15.
9. Cystic Fibrosis Trust Home Intravenous Therapy and Cystic Fibrosis 2007, Cystic Fibrosis Trust, London. http://www.cftrust.org.uk/aboutcf/publications/factsheets/Home_IVs-may07-latest.pdf.
10. Cystic Fibrosis Data Registry Cystic Fibrosis Association Australia 2008, http://www.cysticfibrosis.org.au/pdf/Cystic_Fibrosis_in_Australia_2008.pdf.
11. Cystic Fibrosis Standards of Care Cystic Fibrosis Association Australia 2008, http://www.cysticfibrosis.org.au/pdf/CFA_Standards_of_Care_journal_31_Mar_08.pdf.
12. Cystic Fibrosis Foundation Cystic Fibrosis Care Guidelines 2010, http://www.cff.org/treatments/CFCareGuidelines/Respiratory/.
13. Deitcher S., Fesen M., Kiproff P., Hill P., Li X., McCluskey E., Semba C. Safety and efficacy of alteplase for restoring function in occluded central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial. Journal of Clinical Oncology 2002, 20(1):317-324.
14. Dobbin C., Bye P. Adults with cystic fibrosis: meeting the challenge!. Internal Medicine Journal 2003, 33(12):593-597.
15. Estabrooks C., Floyd J., Scott-Findlay S., O'Leary K., Gushta M. Individual determinants of research utilization: a systematic review. Journal of Advanced Nursing 2003, 43(5):506-520.
16. Fernandes B., Plummer A., Wildman M. Duration of intravenous antibiotic therapy in people with cystic fibrosis 2008, Cochrane Database of Systematic Reviews, No. 2. http://onlinelibrary.wiley.com.ezlibproxy.unisa.edu.au/doi/10.1002/14651858.CD006682.pub3/full.
17. Gabriel J. Vascular device occlusion: causes, prevention and management. Nursing Standard 2011, 25(44):49-55.
18. Geerts W., Bergqvist D., Pineo G., Heit J., Samama C., Lassen M., Colwell C. Prevention of venous thromboembolism. Chest 2008, 133(Suppl. 6):381S-453S.
19. Gorski L., Czaplewski L. Peripherally inserted central catheters & midline catheters for the home care nurse. Home Healthcare Nurse 2004, 22(11):758-773.
20. Goss J. Projection of Australian Health Care Expenditure by Disease, 2003 to 2033 2008, Australian Institute of Health and Welfare. http://www.aihw.gov.au/publicationdetail/?id=6442468187%38tab=2.
21. Hadaway L. Technology of flushing vascular access devices. Journal of Infusion Nursing 2006, 29(3):137-145.
22. Hogan M., Coley B., Shiels W., Allen E., McCoy K. Recurrent deep venous thrombosis complicating PICC line placement in two patients with cystic fibrosis and activated protein C-resistance. Pediatric Radiology 1998, 28(7):552-553.
23. Holt D., Lewis C., Klimpel K., Sloan C., Aguda C. The effects of focused nursing education on 3F Groshong (TM) PICC occlusion rates: The experience of one tertiary pediatric care facility. Journal of the Association for Vascular Access 2010, 15(4):213-221.
24. Infusion Nurses Society Infusion Nursing Standard of Practice 2011, Infusion Nurses Society, Norwood, MA.
25. Jones S., Kaslowsky R. Successful utilization of peripherally inserted central catheters (PICC) for IV antibiotic therapy in pediatric patients with cystic fibrosis. Pediatric Pulmonology 2000, 30(suppl. 20):S535.
26. Khan N., Perera R., Harper S., Rose P. Adaptation and validation of the Charlson index for Read/OXMIS coded databases. BMC Family Practice 2010, 11(1):1.
27. Lacy D., Spencer D., Venkataraman M., Ruiz G., Weller P. Comparison of two percutaneous intravenous "midline" catheters in cystic fibrosis. Journal of Intravenous Nursing 1996, 19(1):28-31.
28. Leick-Rude M., Haney B. Midline catheter use in the intensive care nursery. Neonatal Network 2006, 25(3):189-199.
29. Leone M., Dillon L. Catheter outcomes in home infusion. Journal of Infusion Nursing 2008, 31(2):84-91.
30. Maki D., Kluger D., Crnich C. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clinic Proceedings 2006, 81(9):1159-1171.
31. McKenny M., Fitzgerald M., Scully M. How do I diagnose and manage catheter-related blood stream infections?. Evidence-Based Practice of Critical Care 2010, 263-270.
32. Monthly Index of Medical Specialties MIMS Annual 2010, UBM Medica, Sydney.
33. Morin S., Gifford A., Parker H., Whittaker L., Lahiri T., Cornell A., Hertzig J., Stokes D., Zuckerman J. Complications of intermediate and long-term central venous catheters in CF patients. Pediatric Pulmonology 2007, 42(suppl. 30):411.
34. Moureau N. Vascular safety: it's all about PICCs. Nursing Management 2006, 37(5):22-27.
35. Moureau N., Poole S., Murdock M., Gray S., Semba C. Central venous catheters in home infusion care: outcomes analysis in 50,470 patients. Journal of Vascular and Interventional Radiology 2002, 13(10):1009-1016.
36. Nash E., Helm E., Stephenson A., Tullis E. Incidence of deep vein thrombosis associated with peripherally inserted central catheters in adults with cystic fibrosis. Journal of Vascular and Interventional Radiology 2009, 20(3):347-351.
37. Ngo A., Murphy S. A theory-based intervention to improve nurses' knowledge, self-efficacy, and skills to reduce PICC occlusion. Journal of Infusion Nursing 2005, 28(3):173-181.
38. Parkins M., Parkins V., Rendall J., Elborn S. Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population. Therapeutic Advances in Respiratory Disease 2011, 5(2):105-119.
39. Pellegrino R., Viegi G., Brusasco V., Crapo R., Burgos F., Casaburi R., Coates A., van der Grinten C., Gustafsson P., Hankinson J., Jensen R., Johnson D., MacIntyre N., McKay R., Miller M., Navajas D., Pedersen O., Wanger J. Interpretative strategies for lung function tests. European Respiratory Journal 2005, 26(5):948-968.
40. Raad I., Hanna H., Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. The Lancet Infectious Diseases 2007, 7(10):645-657.
41. Raffini L., Raybagkar D., Blumenstein M., Rubenstein R., Manno C. Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. Journal of Paediatrics 2006, 148(5):659-664.
42. Smith J., Kirksey K., Becker H., Brown A. Autonomy and self-efficacy as influencing factors in nurses' behavioral intention to disinfect needleless intravenous systems. Journal of Infusion Nursing 2011, 34(3):193-200.
43. SPSS PASW Statistics for Windows, Version 18. 0 2009, SPSS Inc., Chicago.
44. Smith S., Sinclair D., Raine R., Reeves B. Understanding Public Health. Health Care Evaluation 2005, http://site.ebrary.com/lib/unisaau/docDetail.action?docID=10175202.
45. Sprizza L., Witko A. The ABCs of DVT. Medsurg Nursing 2003, 12(6):403-405.
46. Stata Stata Statistical Software: Release 11 2009, StataCorp LP, Texas.
47. Syed F., Beeching N. Lower-limb deep-vein thrombosis in a general hospital: risk factors, outcomes and the contribution of intravenous drug use. Quarterly Journal of Medicine 2005, 98(2):139-145.
48. Tolomeo C., Mackey W. Peripherally inserted central catheters (PICCs) in the CF population: one center's experience. Pediatric Nursing 2003, 29(5):355-359.
49. Turner M., Unsworth V., David T. Intravenous long-lines in children with cystic fibrosis: a multidisciplinary approach. Journal of the Royal Society of Medicine 2002, 95(Suppl.41):11-21.
50. Veiraiah A., Shetty H., Routledge P. Prevention and treatment of venous thromboembolism in older people. Reviews in Clinical Gerontology 2008, 18(3):219-228.
51. World Health Organisation International Classification of Diseases 2011, http://www.who.int/classifications/icd/en/.
52. World Health Organisation Genes and Human Disease 2012, http://www.who.int/genomics/public/geneticdiseases/en/index2.html.